L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.
Nature communications
View this publicationNature communications
View this publicationPloS one
View this publicationEBioMedicine
View this publicationScientific reports
View this publicationEuropean radiology
View this publicationGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
View this publicationBiometrical journal. Biometrische Zeitschrift
View this publicationBMC bioinformatics
View this publicationUnited European gastroenterology journal
View this publicationImmunity
View this publication